Physician profile
Ryan Murtha
NPI 1538268271
$1,740.39
in general payments reported to CMS, 2019-2025
14 companies · $508 in 2025
The $508 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $120 · 2023: $678 · 2024: $305 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,457 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,457.10 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $470.42 | 2021-2025 | Breztri, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $412.65 | 2021-2025 | Nucala, Trelegy Ellipta |
| Regeneron Healthcare Solutions, INC. | $125.19 | 2021-2023 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2023 | |
| Inspire Medical Systems, INC. | $123.58 | 2023-2025 | Inspire |
| United Therapeutics Corporation | $92.66 | 2023-2025 | Tyvaso |
| Grifols USA, LLC | $79.14 | 2023-2025 | Prolastin-C Liquid |
| Philips North America LLC | $66.71 | 2025 | Incourage Airway Clearance Therapy |
| Amgen INC. | $61.67 | 2024-2025 | Tezspire |
| Genzyme Corporation | $53.88 | 2024-2025 | |
| Pulmonx Corporation | $45.59 | 2025 | Zephyr Delivery Catheter, Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console |
| Insmed, INC. | $42.93 | 2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $23.10 | 2024 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $17.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Murtha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.